MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis
URI | http://shark.lib.kagawa-u.ac.jp/kuir/metadata/27636 | ||||||
---|---|---|---|---|---|---|---|
Title |
MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis
|
||||||
File |
|
||||||
Description |
Abstract Non-alcoholic steatohepatitis (NASH) is one of the most common causes of chronic liver disease and is considered to be a causative factor of cryptogenic cirrhosis and hepatocellular carcinoma. microRNAs (miRNAs) are small non-coding RNAs that negatively regulate messenger RNA (mRNA). Recently, it was demonstrated that the aberrant expression of certain miRNAs plays a pivotal role in liver disease. The aim of the present study was to evaluate changes in miRNA profiles associated with metformin treatment in a NASH model. Eight-week-old male mice were fed a methionine- and choline-deficient (MCD) diet alone or with 0.08% metformin for 15 weeks. Metformin significantly downregulated the level of plasma transaminases and attenuated hepatic steatosis and liver fibrosis. The expression of miRNA-376a, miRNA‑127, miRNA-34a, miRNA-300 and miRNA-342-3p was enhanced among the 71 upregulated miRNAs, and the expression of miRNA-122, miRNA-194, miRNA-101b and miRNA-705 was decreased among 60 downregulated miRNAs in the liver of MCD-fed mice when compared with control mice. Of note, miRNA profiles were altered following treatment with metformin in MCD-fed mice. miRNA-376a, miRNA‑127, miRNA-34a, miRNA-300 and miRNA-342-3p were downregulated, but miRNA-122, miRNA-194, miRNA‑101b and miRNA-705 were significantly upregulated in MCD-fed mice treated with metformin. miRNA profiles were altered in MCD-fed mice and metformin attenuated this effect on miRNA expression. Therefore, miRNA profiles are a potential tool that may be utilized to clarify the mechanism behind the metformin-induced improvement of hepatic steatosis and liver fibrosis. Furthermore, identification of targetable miRNAs may be used as a novel therapy in human NASH. (医博甲597) |
||||||
Author |
|
||||||
Publication Title |
International Journal of Molecular Medicine
|
||||||
Publication Title Alternative |
Int J Mol Med.
|
||||||
Volume |
35
|
||||||
Issue |
4
|
||||||
Start Page |
877
|
||||||
End Page |
884
|
||||||
Publisher |
Spandidos Publications
|
||||||
Published Date |
2015-02-06
|
||||||
ISSN |
1107-3756
|
||||||
NCID |
AA11445762
|
||||||
PMID |
25672270
|
||||||
DOI |
10.3892/ijmm.2015.2092
|
||||||
Resource Type |
Thesis or Dissertation
|
||||||
Language |
eng
|
||||||
Relation |
PMCID: PMC4356452
|
||||||
Resource URL |
https://doi.org/10.3892/ijmm.2015.2092
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356452/
|
||||||
Rights |
Copyright: © Katsura et al.
"This is the Publisher's Version of the following article: MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis; International Journal of Molecular Medicine; Volume 35 Issue 4 (2015) Pages: 877-884; doi: 10.3892/ijmm.2015.2092, which has been published in final form at https://doi.org/10.3892/ijmm.2015.2092
This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License(CC BY-NC 3.0)(https://creativecommons.org/licenses/by-nc/3.0/). The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
|
||||||
Text Version |
ETD
|
||||||
Grant ID |
博甲第597号
|
||||||
Grant Date |
2014-09-24
|
||||||
Degree Name |
博士(医学)
|
||||||
Grantor |
香川大学
|
||||||
Set |
香川大学
|